Latest Percutaneous coronary intervention Stories
SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Cardium Therapeutics, an operating unit of Taxus Cardium Pharmaceuticals Group Inc.
PLEASANTON, Calif., Aug.
Going to the hospital for a heart attack during evenings, weekends and holidays increases your risk of dying 13 percent compared with people arriving during workday hours.
BASKING RIDGE, N.J., July 29, 2014 /PRNewswire/ -- Regado Biosciences, Inc.
Innovative Technology Adds To Company's Leading Portfolio of Treatment Options for Coronary Artery Disease MARLBOROUGH, Mass., July 23, 2014 /PRNewswire/ -- Continuing to advance the
Although Procedure Volume Expansion Is Faster Than Other Developed Markets, This Will Be Largely Offset By Price Declines, According to Findings from Decision Resources Group BURLINGTON, Mass.,
BASKING RIDGE, N.J., July 9, 2014 /PRNewswire/ -- Regado Biosciences, Inc., (NASDAQ: RGDO) today announced that, further to their decision to voluntarily pause enrollment in their REGULATE-PCI
Efforts to Reduce Overstenting and Price Competition Will Somewhat Restrict Market Expansion, According to Findings from Decision Resources Group BURLINGTON, Mass., July 9, 2014 /PRNewswire/
A new study published in The Lancet compares outcomes for two drugs used to prevent blood clot formation during emergency heart attack treatment.
LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...